156 related articles for article (PubMed ID: 23392461)
21. Cost-effectiveness of dual maternal HIV and syphilis testing strategies in high and low HIV prevalence countries: a modelling study.
Rodriguez PJ; Roberts DA; Meisner J; Sharma M; Owiredu MN; Gomez B; Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Barr-Dichiara M; Jamil MS; Baggaley R; Johnson C; Taylor MM; Drake AL
Lancet Glob Health; 2021 Jan; 9(1):e61-e71. PubMed ID: 33227254
[TBL] [Abstract][Full Text] [Related]
22. Optimizing PMTCT efforts by repeat HIV testing during antenatal and perinatal care in resource-limited settings: A longitudinal assessment of HIV seroconversion.
Mushamiri I; Adudans M; Apat D; Ben Amor Y
PLoS One; 2020; 15(5):e0233396. PubMed ID: 32470004
[TBL] [Abstract][Full Text] [Related]
23. Economic evaluation of universal prenatal HIV screening compared with current 'at risk' policy in a very low prevalence country.
Chowers M; Shavit O
Sex Transm Infect; 2017 Mar; 93(2):112-117. PubMed ID: 28213577
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
[TBL] [Abstract][Full Text] [Related]
25. Universal Rapid Human Immunodeficiency Virus Screening at Delivery: A Cost-Effectiveness Analysis.
Scott RK; Crochet S; Huang CC
Infect Dis Obstet Gynecol; 2018; 2018():6024698. PubMed ID: 29731602
[TBL] [Abstract][Full Text] [Related]
26. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States.
Zaric GS; Bayoumi AM; Brandeau ML; Owens DK
J Acquir Immune Defic Syndr; 2000 Dec; 25(5):403-16. PubMed ID: 11141240
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women(1).
Chen KT; Sell RL; Tuomala RE
Obstet Gynecol; 2001 Feb; 97(2):161-8. PubMed ID: 11165575
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti.
Schackman BR; Neukermans CP; Fontain SN; Nolte C; Joseph P; Pape JW; Fitzgerald DW
PLoS Med; 2007 May; 4(5):e183. PubMed ID: 17535105
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries.
Sweat MD; O'Reilly KR; Schmid GP; Denison J; de Zoysa I
AIDS; 2004 Aug; 18(12):1661-71. PubMed ID: 15280777
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting.
Rely K; Bertozzi SM; Avila-Figueroa C; Guijarro MT
Health Policy Plan; 2003 Sep; 18(3):290-8. PubMed ID: 12917270
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
[TBL] [Abstract][Full Text] [Related]
32. Frequent detection of acute HIV infection in pregnant women.
Patterson KB; Leone PA; Fiscus SA; Kuruc J; McCoy SI; Wolf L; Foust E; Williams D; Eron JJ; Pilcher CD
AIDS; 2007 Nov; 21(17):2303-8. PubMed ID: 18090278
[TBL] [Abstract][Full Text] [Related]
33. Routine screening for HIV infection in booked antenatal women: how justified in developing countries?
Ibekwe PC; Ikeme AC
Afr J Reprod Health; 2001 Aug; 5(2):7-9. PubMed ID: 12471908
[No Abstract] [Full Text] [Related]
34. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.
Halpern MT; Read JS; Ganoczy DA; Harris DR
AIDS; 2000 Apr; 14(6):691-700. PubMed ID: 10807192
[TBL] [Abstract][Full Text] [Related]
35. Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.
Ngambi PG; Kalungia AC; Law MR; Kalemeera F; Truter I; Godman B; Munkombwe D
Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):459-467. PubMed ID: 28770641
[TBL] [Abstract][Full Text] [Related]
36. HIV screening in pregnant women: A systematic review of cost-effectiveness studies.
Bert F; Gualano MR; Biancone P; Brescia V; Camussi E; Martorana M; Thomas R; Secinaro S; Siliquini R
Int J Health Plann Manage; 2018 Jan; 33(1):31-50. PubMed ID: 28556453
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of a repeat HIV test in pregnancy in India.
Joshi S; Kulkarni V; Gangakhedkar R; Mahajan U; Sharma S; Shirole D; Chandhiok N
BMJ Open; 2015 Jun; 5(6):e006718. PubMed ID: 26068507
[TBL] [Abstract][Full Text] [Related]
38. Universal test, treat, and keep: improving ART retention is key in cost-effective HIV control in Uganda.
McCreesh N; Andrianakis I; Nsubuga RN; Strong M; Vernon I; McKinley TJ; Oakley JE; Goldstein M; Hayes R; White RG
BMC Infect Dis; 2017 May; 17(1):322. PubMed ID: 28468605
[TBL] [Abstract][Full Text] [Related]
39. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
40. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
